October 5, 2026Stocks·Bullish·healthcare
Alvotech wins FDA approval to add US manufacturing capacity for Humira biosimilar SIMLANDI
Alvotech received FDA approval for added US manufacturing capacity for its Humira biosimilar SIMLANDI, doubling drug substance capacity at its Reykjavik site.
Detected & updated continuously · Source: Nebula
Story subjects